Art

J-GLOBAL ID：201502218660977142   Reference number：15A1193962

Multicenter large-scale study of prognostic impact of HER2 expression in patients with resectable gastric cancer

切除可能胃癌患者におけるHER2発現の予後の影響に関する多施設大規模研究

Author (12)： KUROKAWA Yukinori (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  MATSUURA Nariaki (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  KIMURA Yutaka (Sakai Municipal Hospital, Osaka, JPN) ,  ADACHI Shinichi (Ikeda City Hospital, Osaka, JPN) ,  FUJITA Junya (NTT West Osaka Hospital, Osaka, JPN) ,  IMAMURA Hiroshi (Toyonaka Municipal Hospital, Osaka, JPN) ,  KOBAYASHI Kenji (Kinki Central Hospital, Itami, Hyogo, JPN) ,  YOKOYAMA Yuhki (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  SHAKER Mohammed Nouri (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  TAKIGUCHI Shuji (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  MORI Masaki (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  DOKI Yuichiro (Osaka Univ. Graduate School of Medicine, Osaka, JPN)
Material： Gastric Cancer (Web)
Volume： 18  Issue： 4  Page： 691-697 (WEB ONLY)  Publication year： Oct. 2015 
JST Material Number： U0618A  ISSN： 1436-3291  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *stomach tumor ,...
Semi thesaurus term： 切除可能 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A1193962&from=J-GLOBAL&jstjournalNo=U0618A") }}

JST classification (5)： Surgical treatment for tumors  (GE03033T) ,  Tumors(=neoplasms)of digestive system  (GH04000D) ,  Postoperative treatment and prognosis  (GC07050M) ,  Biological function  (EB03040U) ,  Epidemiology  (GB03000E)

Reference (19)：

• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-917.
• Hudis CA. Trastuzumab-mechanism of action and use in clinical practice. N Engl J Med. 2007;357:39-51.
• Seshadri R, Firgaira FA, Horsfall DJ, McCaul K, Setlur V, Kitchen P. Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. J Clin Oncol. 1993;11:1936-42.
• Dawood S, Broglio K, Buzdar AU, Hortobagyi GN, Giordano SH. Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review. J Clin Oncol. 2010;28:92-8.
• Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687-97.

Terms in the title (8)： 胃 ,  癌患者 ,  HER2 ,  発現 ,  予後 ,  施設 ,  大規模 ,  研究